Clinical Trial: Liso-Cel in Relapsed/Refractory Marginal Zone Lymphoma

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777120) titled 'Liso-Cel in Relapsed/Refractory Marginal Zone Lymphoma' on Aug. 18.

Brief Summary: This non-interventional study will use information already reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) registry during routine clinical care. The study will assess the long-term safety and effectiveness of lisocabtagene maraleucel in participants with relapsed/refractory marginal zone lymphoma.

Study Start Date: March 24

Study Type: OBSERVATIONAL

Condition: Marginal Zone Lymphoma

Intervention: BIOLOGICAL: lisocabtagene maraleucel

As per United States prescribing information

Recruitment Status: ACTIVE_...